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Abstract
In cell senescence, cultured cells cease proliferating and acquire aberrant gene expression patterns. MicroRNAs (miRNAs)
modulate gene expression through translational repression or mRNA degradation and have been implicated in senescence.
We used deep sequencing to carry out a comprehensive survey of miRNA expression and involvement in cell senescence.
Informatic analysis of small RNA sequence datasets from young and senescent IMR90 human fibroblasts identifies many
miRNAs that are regulated (either up or down) with cell senescence. Comparison with mRNA expression profiles reveals
potential mRNA targets of these senescence-regulated miRNAs. The target mRNAs are enriched for genes involved in
biological processes associated with cell senescence. This result greatly extends existing information on the role of miRNAs
in cell senescence and is consistent with miRNAs having a causal role in the process.
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Introduction
The accumulation of senescent cells, and their prolonged
activity, disturbs the microenvironment of aging tissues, thereby
compromising tissue function and contributing to age-related
pathologies [1–3]. Hence there is great interest in determining the
mechanisms by which senescence contributes to the aging process.
Cell senescence, usually accepted as a manifestation of aging at the
cellular level, occurs when cultured cells cease to proliferate,
remaining viable and metabolically active but undergoing
profound changes in gene expression and morphology [1,4,5].
Various triggers such as telomere uncapping, DNA damage, and
oncogene activation can evoke senescence; such triggers can
engage several mechanisms ranging from cell cycle arrest to
activation of tumor suppressors. However, all senescing cells
undergo profound changes in gene expression [6,7]. Comprehen-
sive gene expression profiling has identified genes in cell cycle,
insulin growth factor, interferon, MAP kinase and oxidative stress
pathways as consistently dysregulated during cell senescence [8].
Altered gene expression gives rise to the senescent phenotype, and
is well established as part of the mechanisms and pathways that
activate the senescence program in cells [7]. However, the factors
responsible for the alterations of gene expression during
senescence remain elusive.
MicroRNAs (miRNAs) are key modulators of gene expression in
various biological and pathological processes [9,10]. These RNAs,
,22 nucleotides in size, act as sequence guides that direct
Argonaute protein complexes to mRNAs, where they decrease
protein synthesis through translational repression or mRNA
degradation [11,12] and thereby influence many basic cellular
processes [13,14] and diseases [15,–17]. Changes in miRNA
expression levels occur in cellular senescence and organismal aging
[18,19], and have been linked to changes in levels of mRNAs that
are putative targets of specific miRNAs [20–22].
To date, studies exploring the role of miRNAs in senescence
have relied on microarrays to assay miRNA expression. Deep
sequencing, a set of technologies that produce very large amounts
of sequence data from nucleic acid specimens, is rapidly replacing
microarrays as the technology of choice for quantifying and
annotating miRNAs [23,24]. Deep sequencing has superior ability
to capture the scale and complexity of whole transcriptomes [25].
In particular, short read deep sequencing (e.g. Illumina, Solid) is
appropriate for miRNAs because a complete miRNA can be
sequenced with a single read. While array design relies on
knowledge of the miRNAs being interrogated, deep sequencing
allows discovery of novel miRNAs. Furthermore, microarray
methods lack the dynamic range to detect and quantify low
abundance transcripts, but deep sequencing can identify miRNAs
that are expressed at levels below the threshold of detection by
microarrays. In addition, deep sequencing eliminates background
problems that result from cross-hybridization in microarrays, thus
facilitating interpretation of the signal and obviating the non-linear
data manipulation steps required by microarrays. Therefore, the
application of deep sequencing to miRNA studies has the potential
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functionally significant miRNAs. Deep sequencing has not
previously been applied to analysis of miRNA expression in cell
senescence. In this study, we conducted a deep characterization of
miRNA expression in young and senescent IMR90 human
fibroblasts, and predicted biological processes possibly regulated
by changes in miRNA expression during senescence.
Results
Deep sequencing of miRNAs from young and senescent
fibroblasts and analysis with miRDeep2
To investigate miRNA expression during cell senescence, we
used Illumina sequencing to generate and analyze 11,382,713 and
9,082,893 raw sequencing reads of small RNAs isolated from
young and senescent IMR90 human lung fibroblasts, respectively.
The reads were mapped to the human genome (NCBI36/hg18)
and analyzed by miRDeep2, an algorithm based on the miRNA
biogenesis model. It aligns sequencing reads to potential hairpin
structures in a manner consistent with Dicer processing, and
assigns log-odds scores to measure the probability that hairpins are
true miRNA precursors. The output of this analysis is a scored list
of known and novel miRNAs with their expression levels.
MiRDeep2 detected 452 known miRNAs that passed the relatively
stringent score cut-off of 4, which provides a signal-to-noise ratio
of 15.6 (Table S1). (To detect miRNAs in deep sequencing data by
miRDeep2, a score cutoff corresponding to a prediction signal-to-
noise ratio .10 is often used.) MiRDeep2 predicted 46 potential
novel miRNAs at the same score cut-off of 4 (Table S1). Removal
of loci matching other RNA genes or genomic repeats reduced this
list to 20 candidate novel miRNAs (Table 1). Illustrative examples
of novel miRNAs are depicted in Fig. 1. The novel miRNA in
Fig. 1A maps to a conserved genomic region, and is not annotated
in the ‘Non-coding RNA Genes’ and ‘sno/miRNA’ UCSC tracks.
The novel miRNA in Fig. 1B is not conserved, and is derived from
an intron of the RAB40B gene. In both novel miRNAs, many
more sequencing reads map to the senescent than to the young
sample, indicating an induction by senescence.
Differentially regulated known miRNAs in young and
senescent fibroblasts
To test for differential miRNA expression between young and
senescent fibroblasts, we used expression values generated by
miRDeep2 as input for the Bioconductor DESeq package [26].
DESeq uses a negative binomial distribution model to test for
differential expression in deep sequencing datasets. 141 miRNAs
were induced by senescence and 131 were repressed (Table S2).
Many of these have previously been identified as senescence-
regulated in microarray studies [20,27,28], with some differences
that may reflect differences in cell types and senescence models.
However the results include many miRNAs not previously
identified as senescence-associated: for example, mir-432 is highly
induced by senescence (Fig. 2A), mir-145 is repressed (Fig. 2B),
and others are depicted in Fig. 3.
Potential target genes regulated by senescence-induced
miRNA expression changes
An individual miRNA may regulate hundreds of mRNAs; this
ability to modulate gene expression gives miRNAs considerable
influence on physiology and pathology. We computationally
identified mRNA targets of miRNAs using the prediction
algorithm TargetScan in ExprTargetDB [29], and identified
mRNA expression patterns correlated with miRNA expression
changes (see materials and methods for details of the steps used in
matching miRNA and mRNA expression data). We used affy and
limma Bioconductor packages to generate senescence-associated
gene expression profiles from Affymetrix and two-color microarray
raw data files of young and senescent IMR90 and MRC5
fibroblasts obtained from the GEO repositories GSE19018 and
GSE15919, respectively. The differentially expressed genes were
separated into upregulated and downregulated genes. We first
matched the in silico predicted miRNA target genes to the mRNA
expression obtained from the Affymetrix microarray study of
IMR90 fibroblasts. These comparisons revealed 386 genes
potentially downregulated by senescence-induced miRNA over-
expression (Table S3), and 131 genes potentially upregulated by
senescence-induced miRNA underexpression (Table S4). We then
used a three-way Venn diagram to match the in silico predicted
miRNA target genes to the mRNA expression obtained from the
Affymetrix microarray study of IMR90 fibroblasts and the mRNA
expression obtained from the two-color microarray study of
MRC5 fibroblasts. This comparison revealed 143 genes potentially
downregulated by senescence-induced miRNA overexpression in
both types of fibroblasts (Table S5), and 36 genes potentially
upregulated by senescence-induced miRNA underexpression
(Table S6).
Biological processes regulated by miRNA changes during
senescence
To functionally annotate the genes identified as potentially
regulated by miRNAs during senescence, we used DAVID and
Gene Ontology. DAVID Functional Annotation Clustering
feature identifies GO terms associated with genes, and then
clusters the most relevant GO terms into smaller and biologically
meaningful groups. This functional annotation reveals the
biological processes targeted by miRNA expression changes
during senescence. Genes repressed by senescence-upregulated
miRNAs produced five clusters that have enrichment scores higher
than 1.3 (Table 2). Terms related to positive regulation of cell
proliferation are by far the most highly represented and enriched.
Other enriched biological processes suppressed by miRNA
upregulation during senescence include regulation of cellular
metabolic processes, nitrogen compound metabolic processes, lung
development, and cell differentiation. The KEGG pathway ‘actin
cytoskeleton’ was also significantly enriched (Figure S1), suggesting
that miRNAs regulate cytoskeletal structure changes that give rise
to the enlarged and flattened cell morphology characteristic of the
senescence phenotype. Targets of miRNAs downregulated by
senescence were also organized into five significant annotation
clusters (Table 3), including positive regulation of cell adhesion,
negative regulation of apoptosis, and cell cycle arrest. Inhibition of
proliferation and resistance to apoptosis are hallmarks of
senescence [5,30], and inhibition of biosynthetic pathways may
influence the cessation of growth during senescence. Conversely,
stimulation of protein metabolism and modification are consistent
with evidence that anabolic processes are enhanced during cellular
senescence [31]. Functional annotation of genes identified as
potentially regulated by miRNAs during senescence in two types of
fibroblasts, IMR90 and MRC5, revealed clusters very similar to
the ones obtained from the annotation of genes identified in
IMR90 fibroblasts only (Table 4). Notably, senescence-induced
changes in miRNA levels seem to be associated with suppression of
cell proliferation and cellular metabolic processes and stimulation
of cell adhesion in two types of fibroblasts, IMR90 and MRC5.
To identify miRNAs that regulate the biological processes
highlighted in the annotation clusters, genes associated with all
GO terms within each annotation cluster were pooled and used to
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prediction algorithm, specifying a score cutoff of 1. A gene list
pooled from all GO terms within a given annotation cluster is
much more comprehensive than genes selected from individual
GO terms. MiRNAs with significant ExprTarget prediction scores
(Tables 2 and 3) were considered to be key regulators of the
biological processes that were altered during senescence.
Discussion
To further extend understanding of the role of miRNAs in cell
senescence, we used deep sequencing to interrogate the miRNA
transcriptomes of young and senescent IMR90 fibroblasts. Even
though microarrays have been used to profile miRNA expression
in senescence [27,32–34], the microarray technology suffers from
limitations in sensitivity and specificity [35–37]. Deep sequencing
technology overcomes the disadvantages of microarrays and
generates millions of small RNA sequence reads, to measure
absolute abundance and to discover novel microRNAs that have
evaded previous discovery efforts. MiRDeep2 analysis of the
sequencing reads detected 141 known miRNAs that were induced
by senescence and 131 that were repressed, and discovered 20
novel miRNAs. Some of the novel miRNAs are differentially
expressed between young and senescent fibroblasts, while still
showing the characteristic pattern of higher expression of the
mature miRNA over the star and loop sequences. These novel
sequences were missed by traditional analyses because they tend to
be expressed at low levels and they are located within unannotated
regions of the genome. The low expression levels of novel miRNAs
are effectively detected because of the high sensitivity of deep
sequencing; low expression of novel miRNAs has been observed in
other studies, suggesting that the more abundant miRNAs have
largely already been discovered [38]. The targets and functions of
the novel miRNAs remain to be investigated.
Among the known miRNAs detected in our study, members of
the highly conserved let-7 family (let-7a, let-7f, let-7e, let-7i and
let-7g) were the most abundant, with read counts up to 1.7 million
and highly significant miRDeep2 detection scores. We found that
senescence increased let-7 expression, as previously observed in
microarray miRNA profiling studies [27]. Let-7 is among several
miRNAs currently considered as tumor suppressors [39,40], which
is consistent with the view that senescence evolved as a tumor-
suppressive mechanism to mitigate the hazard that cancer poses to
longevity [5,40]. Expression of let-7 is abnormal in 9 cancer types
[41,42]. Let-7 miRNA overexpression was shown to be associated
with senescence in fibroids [43] and in skeletal muscle of aged
humans, and was proposed to contribute to decreased muscle cell
renewal and regeneration [44]. Taken together, these findings
suggest that let-7 miRNAs play a key role in the control of cell
senescence.
Members of the miR-449 family were among the most highly
induced miRNAs in senescent fibroblasts. Consistent with a
Table 1. Novel miRNAs predicted by miRDeep2 in IMR90 fibroblast data sets.
Novel miRNA Id
1 Genomic location
2 MiRDeep2 score
3 Probability
4 Total
5 Mature
6 Star
7
chr1_1934 chr1:98283418-98283473:- 768.3 72 +/2 10%% 1505 1485 20
chr12_17303 chr12:107915210-107915253:+ 307.8 72 +/2 10%% 602 601 1
chr6_9853 chr6:1335558-1335615:- 47.2 72 +/2 10%% 98 87 11
chr7_11235 chr7:101898924-101898982:+ 39.3 72 +/2 10%% 75 74 1
chr11_16723 chr11:121532114-121532177:- 26 72 +/2 10%% 50 30 20
chr2_3531 chr2:208327785-208327842:+ 21.1 72 +/2 10%% 40 39 1
chr2_3059 chr2:111795064-111795130:- 17.6 72 +/2 10%% 42 41 1
chr19_24258 chr19:2713642-2713692:- 15 72 +/2 10%% 35 34 1
chr2_4756 chr2:233123445-233123507:- 14.2 72 +/2 10%% 18 17 1
chr12_16965 chr12:47506359-47506417:+ 13.8 72 +/2 10%% 33 32 1
chr17_23138 chr17:78219400-78219465:- 12.4 72 +/2 10%% 22 19 3
chr17_21914 chr17:26926413-26926479:+ 10.4 72 +/2 10%% 26 25 1
chr2_4865 chr2:239938364-239938425:- 10 72 +/2 10%% 10 9 1
chr5_8282 chr5:9106935-9106998:- 8 74 +/2 9%% 13 9 4
chr15_20416 chr15:72490756-72490821:- 7.4 75 +/2 9%% 13 11 2
chr13_18468 chr13:49450842-49450905:- 6.2 76 +/2 8%% 11 10 1
chr11_16105 chr11:13441281-13441335:- 5.9 75 +/2 8%% 48 48 0
chr6_9790 chr6:150157484-150157534:+ 4.9 66 +/2 8%% 48 48 0
chr10_14949 chr10:72362347-72362419:- 4.7 66 +/2 8%% 38 38 0
chr6_9666 chr6:114132759-114132810:+ 4.4 66 +/2 8%% 42 42 0
1A unique identification containing the chromosome and an arbitrary number.
2Location of the miRNA precursor in the human genome NCBI36/hg18.
3The miRDeep2 score represents the log-odds probability of a sequence being genuine miRNA precursor versus the probability that it is a background hairpin, given the
evidence from the data.
4The estimated probability that a predicted novel miRNA with a score of this or higher is a true positive.
5The sum of read counts that map to the predicted mature, loop and star miRNAs. The number of reads that map to the predicted miRNA loop is zero for all listed novel
miRNAs.
6The number of reads that map to the predicted mature miRNA.
7The number of reads that map to the predicted star miRNA.
doi:10.1371/journal.pone.0020509.t001
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20509Figure 1. Examples of novel miRNAs discovered by deep sequencing of IMR90 fibroblasts. Expression of both novel miRNAs is increased
by senescence. A) Novel miRNA located in a conserved genomic region. Shown are screenshots from the UCSC genome browser, displaying the
Illumina sequencing reads (blue: young IMR90; red: senescent IMR 90), and the novel precursor miRNA (black) predicted by miRDeep2 with
provisional id chr1_1934 (see Table 1). The mammalian conservation track is at the bottom (deep blue). UCSC genome browser tracks for non-coding
RNAs are shown, with no RNAs annotated in this region. The ‘‘stacks’’ of sequence reads identify the mature miRNA, which is more abundant in the
senescent IMR90 cells. The coverage depth (number of reads, y-axis) shows few reads mapping to the star region of the miRNA precursor. B) Novel
miRNA with provisional id chr17_23138 (see Table 1) predicted to map to an intron by miRDeep2. The same UCSC genome browser tracks as in A are
shown. The precursor miRNA is in black. Note the scale on the y-axis: this novel miRNA is less abundant than the example in A.
doi:10.1371/journal.pone.0020509.g001
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senescence, miR-449 has been shown to inhibit cell cycle
progression at G1 phase by targeting CDK6 and CDC25A,
which are pivotal to G1/S-phase transition [45]. Also, miR-499
was found to be significantly upregulated in senescent human
mesenchymal stem cells, with the potential to regulate all four of
the senescence induction types namely, telomere attrition,
oxidative stress, oncogene expression and DNA damage signaling
[20]. Among the miRNAs we found to be downregulated by
senescence is the miR-17-92 cluster, which is a polycistron
Figure 2. Examples of known miRNAs that are regulated in IMR90 senescence, showing sequence depth. UCSC genome browser views
of two miRNAs aligned to the human genome. Reads from young IMR90 cells are shown in blue, and reads from senescent cells in red (number of
reads is shown on the y-axis). (A) mir-432; (B) mir-145. The miRNAs (in red) labeled on the snoRNABase/miRBase track represent the miRNA precursors;
note that the sequence depth of the mature miRNA, but not the star region, changes in both cases.
doi:10.1371/journal.pone.0020509.g002
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-92a-1). The expression of all 6 members was decreased in
senescent cells with a substantial fold change (8.0, 7.8, 6.4, 10.8,
11.1, and 4.1, respectively). MiR-17-92 is overexpressed in human
cancers, and promotes tumorigenesis mainly by inhibiting
oncogene-induced senescence [46,47]. Given the anti-senescence
activity of miR-17-92, our finding that all miR-17-92 members are
sharply repressed with senescence suggests that its very low levels
may initiate and/or sustain the senescence program. Furthermore,
miR-19b was found to be downregulated in several human
replicative and organismal aging models [19], and has been
identified as an oncogene that activates the AKT/mTOR
pathway, which modulates organismal life spans [48].
miRNA microarray studies have reported four upregulated
miRNAs (miR-152, -410, -431, and -493) and four downregu-
lated miRNAs (miR-15a, -20a, -25, and -155) in both replicative
and stress-induced senescence [28]. Decreased expression of one
of these, miR-155, was observed in senescent BJ fibroblasts,
aged primary human WI-38 fibroblasts, and peripheral blood
mononuclear cells from older individuals [49–51]. In our study,
all of these eight miRNAs were regulated in the same way.
Another study reported twelve miRNAs as senescence regulators
[20]. Four of twelve reported miRNAs (miR-217, -34a, -369-5p,
and -20a) were regulated in the same way in our study; absence
of the others in our study may reflect differences in cell types
and senescence models. Furthermore, miR-217 has been
reported to play a role in endothelial senescence and is
implicated in the pathogenesis of atherosclerosis [52]. The
expression of miR-217 increases in aged endothelial cells and
promotes senescence through inhibition of SirT1, which is
known to promote longevity and mediates the beneficial effects
of calorie restriction.
Our study identified many miRNAs that are reported here for
the first time as differentially regulated by senescence, adding to
the increasing evidence for miRNA regulation of the senescent
program. Mir-432 is highly induced by senescence in our data as
illustrated in Fig. 2A, but was never reported in previous cell
senescence microarray studies. It is mentioned in the literature
only as abundant in the earliest stage of fetal development [53],
and has a putative binding site in the 39 UTR of some endothelial
cell-restricted genes [54]. Other miRNAs found in our study to be
affected during senescence (Fig. 3), but not reported in previous
senescence studies, include miR-1246, miR-584 and miR-323,
which are implicated in certain cancers [55–57]. Further
investigation of these miRNAs may shed new light on the roles
and mechanisms of miRNAs in cellular senescence.
To improve the identification of target genes of the miRNAs
that changed expression during senescence, we adopted an
approach based on co-analysis of changes in both miRNA and
mRNA expressions. The mRNA transcripts that were detected by
microarrays as differentially expressed during senescence, and
simultaneously predicted in silico as targets of differentially
expressed miRNAs, were considered as potential target genes
regulated by senescence-induced miRNA changes. Matching the
in silico predicted target genes with the differentially regulated
mRNA transcripts derived from microarrays may minimize the
false positives and negatives obtained from in silico prediction. In
total, 386 genes were predicted to be the targets of up-regulated
miRNAs in senescent cells, while 131 genes were predicted as
targets of down-regulated miRNAs (Tables S3 and S4). We also
included another fibroblast type, MRC5, in the matching analysis.
We found 143 genes potentially downregulated by senescence-
induced miRNA overexpression in both types of fibroblasts,
IMR90 and MRC5, and 36 genes potentially upregulated by
Figure 3. miRNAs differentially regulated in IMR90 senescence. MiRNAs are labeled with miRBase terminology. The x-axis denotes the fold
change in sequence reads between young and senescent IMR90 cells: miRNAs overexpressed during senescence have positive values and miRNAs
underexpressed during senescence have negative values. These miRNAs were selected for display because they have high expression level (sequence
read counts) in at least one of the states (young or senescent) and show a high fold change. For a complete list of differentially expressed miRNAs,
see Table S2.
doi:10.1371/journal.pone.0020509.g003
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To establish the impact of these miRNA targets on senescence, we
used functional annotation to identify the most relevant and
meaningful biological processes and pathways associated with
these potential target genes. Terms related to positive regulation of
cell proliferation are by far the most highly represented and
enriched among the target genes suppressed by miRNA
upregulation during senescence. This is consistent with a pivotal
role for miRNAs in senescence regulation, since inhibition of
proliferation-promoting genes is the hallmark of senescence [5]. In
parallel to the inhibition of cell proliferation during senescence, we
found that miRNAs tend to promote negative regulation of
apoptosis; terms such as ‘negative regulation of apoptosis’ and
‘negative regulation of programmed cell death’ were significantly
enriched among the target genes stimulated by miRNA downreg-
ulation during senescence. The cell commitment to senescence
instead of apoptosis is pathologically relevant because, while
apoptosis eliminates damaged or stressed cells, senescence arrests
their growth and allows damaged cells to persist and acquire
abnormalities that alter tissue microenvironment and promote
aging and cancer. Our data suggests that miRNAs may sway the
cellular decision to commit to senescence instead of apoptosis.
Senescent fibroblasts are known to acquire resistance to apoptotic
stimuli [30], however, it remains unclear what makes a cell
undergo senescence or apoptosis [5]. The miRNAs found here to
be potential regulators of apoptosis resistance in senescent cells
could be used to investigate the mechanisms responsible for
committing cells to senescence instead of apoptosis.
Other enriched biological processes suppressed by miRNA
upregulation during senescence include positive regulation of
cellular metabolic and biosynthetic processes, indicating an
inhibition of biosynthetic pathways, which may reflect the cessation
of growth duringsenescence.However, GO terms related to protein
metabolic processes and biopolymer modification were significantly
enriched among the target genes stimulated by miRNA downreg-
ulation during senescence. The stimulation of protein metabolism
and biopolymer modification is consistent with evidence that
anabolic processes are enhanced during cellular senescence [31]
and could be part of metabolic alterations responsible for the
increase in cell volume and mass resulting in the enlarged and
flattened cell morphologythat is typical ofsenescence. Furthermore,
the KEGG pathway ‘actin cytoskeleton’, which is important for cell
morphology, was also significantly enriched (Figure S1); its
dysregulation may be involved in rearrangingcytoskeletal structures
to give rise to the flattened cell morphology. We also found that
terms related to positive regulation of cell adhesion were
significantly enriched among the target genes stimulated by miRNA
downregulation during senescence. Since the capability of cells to
adhere to each other and to the extracellular matrix is linked to
cytoskeleton organization and cellular shape, the changes in cell
adhesion regulation may contribute to the morphological changes
induced by senescence. In support of our result, a previous
functional study of senescence-associated miRNA targets showed
enrichment in pathways involved in cytoskeletal remodeling [20].
Thus, miRNAs may regulate the morphological changes charac-
teristic of the senescence phenotype.
Table 2. Functional annotation clusters of enriched GO biological processes predicted to be suppressed by miRNA upregulation in
senescent IMR90 fibroblasts.
Cluster # GO biological processes Count
2 P-Value
3 MiRNAs
4
Cluster 1 (ES=3.5)
1 GO:0042127,regulation of cell proliferation 36 0.0001 hsa-miR-1; 15b; 16; 25; 29a; 30; 30b; 30c;
34a; 103; 128a; 137; 140; 141; 206; 210;
302a; 302b; 302c; 302d
GO:0008284,positive regulation of cell proliferation 23 0.0002
Cluster 2 (ES=3.4) GO:0060541,respiratory system development 11 0.0002 hsa-miR-10a; 10b; 21; 145; 148a; 148b;
152; 155; 181a; 181c; 190; 196a; 196b;
198; 367; 516b; 524-5p; 576-3p; 590-5p;
630
GO:0030324,lung development 10 0.0004
GO:0030323,respiratory tube development 10 0.0005
Cluster 3 (ES=2.8) GO:0031323,regulation of cellular metabolic process 108 0.0002 hsa-miR-16; 22; 25; 30; 30b; 30c; 34a;
101; 137; 140; 141; 155; 183; 210; 218;
223; 373; K12-11
GO:0051171,regulation of nitrogen compound metabolic process 90 0.0005
GO:0031326,regulation of cellular biosynthetic process 90 0.0008
Cluster 4 (ES=2.6) GO:0051173,positive regulation of nitrogen metabolic process 29 0.0008 hsa-miR-1; 7; 10a; 15b; 16; 19a; 25; 30;
34a; 103; 107; 128a; 137; 140; 141; 148a;
148b; 195; 206; 210
GO:0031328,positive regulation of cellular biosynthetic process 30 0.0010
GO:0031325,positive regulation of cellular metabolic process 35 0.0017
GO:0010557,positive regulation of macromolecule biosynthetic
process
28 0.0020
Cluster 5 (ES=2.1) GO:0045597,positive regulation of cell differentiation 12 0.0016 hsa-miR-1; 7; 10a; 19a; 22; 30d; 128a;
134; 140; 148a; 148b; 152; 155; 190;
196a; 196b; 206; 218; 223; 373
GO:0045595,regulation of cell differentiation 23 0.0020
1,2,3,4are the same as in Table 3.
doi:10.1371/journal.pone.0020509.t002
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known miRNAs that are differentially regulated with IMR90 cell
senescence, and a number of novel miRNAs. Our results included
known miRNAs that have not been previously reported as
differentially regulated by senescence in microarray profiling
studies, thus adding to the increasing evidence for miRNA
contribution to senescence. Functional analysis of mRNA
transcripts targeted by senescence-regulated miRNAs indicates
that miRNAs may be key contributors to the cellular changes that
make up the senescence phenotype. Hence, our findings could be
used to generate new hypotheses to be tested in follow-up studies
designed to further elucidate the role of miRNAs in senescence.
Materials and Methods
Cell culture
IMR90 fetal lung fibroblasts were purchased from ATCC
(CCL-186) and maintained as described [58]. Briefly, cells were
grown in DMEM supplemented with 10% FBS, and maintained
at 37uCi n5 %C O 2. Cells were serially passaged and were
considered senescent when they stopped dividing for 2 weeks. In
this study ‘‘young’’ IMR90 cells are cells grown for less than 14
passagings; senescent cells were passaged more than 34 times, and
had ceased further growth.
RNA extraction and small RNA library construction
Total RNA, including small RNAs, was extracted from young
and senescent IMR90 cells with the QIAGEN miRNeasy Mini
Kit. Integrity of total RNA was checked with an Agilent 2100
Bioanalyzer. A total of 10 mg of small-RNA-enriched total RNA
was electrophoresed on an 18% denaturing polyacrylamide gel
with NEB miRNA markers, the gel stained with SYBR Gold,
and the region corresponding to the 18–30 nucleotide bands in
the marker lane was excised. Small RNA was eluted from the
gel fragment and purified by standard methods. Illumina
libraries were constructed from RNA specimens using the
Illumina Small RNA Library kit, following the manufacturer’s
protocol. Briefly, 59 and 39 adapters were ligated to gel-purified
small RNA in two separate steps, each followed by acrylamide
gel purification. The ligation products were used for cDNA
synthesis, followed by acrylamide gel purification and a final
step of PCR amplification to generate libraries. One mlo fe a c h
library was loaded on an Agilent Technologies 2100 Bioanaly-
zer to check size, purity, and concentration. Libraries were
sequenced on an Illumina GAII instrument to generate 36 base
reads. Sequencing data was processed with the Illumina pipeline
v1.3.2. The MIAME-compliant sequencing data has been
deposited in Gene Expression Omnibus (GEO) with accession
number GSE27404.
Table 3. Functional annotation clusters of enriched GO biological processes predicted to be stimulated by miRNA downregulation
in senescent IMR90 fibroblasts.
Cluster # GO biological processes Count
2 P-Value
3 MiRNAs
4
Cluster 1 (ES=3.5)
1 GO:0045785,positive regulation of cell adhesion 5 0.001 let-7b; LNA_let-7b; hsa-miR-1; 30a-3p; 34a;
124; 153; 155; 194; 203; 221; 222; 483-5p;
491-3p; 492; 495; 573; 584; 640; 891a
GO:0030155,regulation of cell adhesion 6 0.004
GO:0022407,regulation of cell-cell adhesion 3 0.012
Cluster 2 (ES=3.4) GO:0043412,biopolymer modification 25 0.000 let-7b; LNA_let-7b; hsa-miR-1; 26b; 27a;
27b; 29a; 29b; 29c; 30a-3p; 34a; 124; 138;
145; 153; 155; 181a; 182; 183; 212
GO:0044267,cellular protein metabolic process 29 0.011
GO:0019538,protein metabolic process 31 0.034
Cluster 3 (ES=2.8) GO:0007050,cell cycle arrest 5 0.008 let-7b; LNA_let-7b; hsa-miR-1; 15a; 15b;
19b; 21; 24; 27a; 30a-3p; 96; 130a; 132; 153;
182; 183; 186; 203; 212; 217
GO:0043067,regulation of programmed cell death 14 0.010
GO:0043066,negative regulation of apoptosis 8 0.020
GO:0043069,negative regulation of programmed cell death 8 0.021
GO:0060548,negative regulation of cell death 8 0.022
Cluster 4 (ES=2.6) GO:0043434,response to peptide hormone stimulus 6 0.007 hsa-miR-1; 16; 21; 27a; 27b; 29a; 29b; 29c;
30b; 30c; 101; 132; 145; 153; 182; 206; 212;
214; 503; 549
Cluster 5 (ES=2.1) GO:0016477,cell migration 7 0.020 hsa-miR-1; 19a; 19b; 27b; 29a; 29b; 29c;
30a-3p; 34b; 124; 138; 155; 183; 200b; 200c;
218; 369-3p; 582-3p
GO:0048870,cell motility 7 0.032
1An enrichment score (ES) of 1.3 is equivalent to a non-log scale value of 0.05.
2The gene members, which belong to an annotation term.
3Fisher Exact p-value representing the degree of enrichment of the GO term.
4The miRNAs predicted to regulate the biological processes in the corresponding functional cluster. We show the top 20 miRNAs with highest ExprTarget prediction
scores.
doi:10.1371/journal.pone.0020509.t003
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Raw small RNA sequencing data were analyzed with miRDeep2
[59], a probabilistic algorithm based on the miRNA biogenesis
model and designed to detect miRNAs from deep sequencing reads.
Briefly,miRDeep2 pre-processed raw sequencing readsbyremoving
the 39 adapter sequence and discarding reads shorter than 18
nucleotides, before aligning reads to the human genome (NCBI36/
hg18). Only reads that mapped perfectly to the genome five or less
times were usedfor miRNA detection,since human miRNAsusually
map to few genomic locations. MiRDeep2 estimates expression
levels of known miRNAs, and also identifies novel miRNAs. The
situation with deep sequencing is quite different from a microarray
experiment, where only known miRNAs appear as features: any
genomic sequence may potentially appear in the sequence dataset,
and the informatics task is to determine which of these are miRNAs.
Small RNAs identified by short read sequencing are derived from
longerRNAs,andmayormaynotbetruemiRNAs.ThemiRDeep2
algorithm isbased on themiRNAbiogenesismodel; italigns reads to
potential hairpin structures in a manner consistent with Dicer
processing and assigns scores that measure the probability that
hairpins are true miRNA precursors. MiRDeep2 then uses known
characteristics of miRNA biogenesis to score the likelihood that the
reads are derived from true miRNAs: a small RNA derived from the
59 end of a predicted precursor is likely to be a miRNA if it is highly
abundant relative to small RNAs derived from loop and star regions
of the precursor, and less likely to be a true miRNA if it is present in
similar proportions to the loop and star. The miRDeep2 algorithm
uses this principle to produce a log-odds score that a small RNA is a
true miRNA; it outputs a scored list of known and novel miRNAs as
well as their expression levels.
Statistical analysis of differential miRNA expression
In addition to identifying mature miRNAs in deep sequenced
small RNA samples, miRDeep2 also generates expression values
for the detected miRNAs. To test for differential miRNA
expression between young and senescent fibroblasts, expression
data for known miRNAs produced by miRDeep2 was used as
input for the Bioconductor DESeq package [26]. DESeq uses a
negative binomial distribution model to test for differential
expression in deep sequencing datasets. The list of differentially
expressed miRNAs produced by DESeq was further filtered to
remove miRNAs with less than 10 reads in both samples, and fold
change between samples less than 1.5.
Potential target genes regulated by senescence-induced
miRNA expression changes
To identify mRNA expression patterns associated with miRNA
expression changes, we matched miRNA and mRNA expression
data, and considered a miRNA to be regulatory only if expression
levels of miRNA and its known mRNA targets are anti-correlated.
This analysis was carried out in 3 steps:
Step 1. In silico prediction of genes targeted by miRNAs
displaying differential expression in senescent
fibroblasts. To functionally characterize the differentially
expressed miRNAs, we identified their target transcripts, using
ExprTargetDB [29], which uses a public database of human
Table 4. Functional annotation clusters of enriched GO biological processes predicted to be regulated by miRNA changes in
senescent IMR90 and MRC5 fibroblasts.
GO biological processes predicted to be suppressed by miRNA upregulation
Cluster # GO biological processes Count
2 P-Value
3
Cluster 1 (ES=2.2)
1 GO:0031325,positive regulation of cellular metabolic process 19 0.0006
GO:0080090,regulation of primary metabolic process 45 0.0011
GO:0031328,positive regulation of cellular biosynthetic process 15 0.0025
GO:0051171,regulation of nitrogen compound metabolic process 38 0.0052
Cluster 2 (ES=2.0) GO:0042127,regulation of cell proliferation 16 0.0035
GO:0008284,positive regulation of cell proliferation 10 0.0103
Cluster 3 (ES=1.8) GO:0030324,lung development 5 0.0110
GO:0030323,respiratory tube development 5 0.0122
Cluster 4 (ES=1.7) GO:0045595,regulation of cell differentiation 11 0.0108
GO:0045637,regulation of myeloid cell differentiation 4 0.0232
Cluster 5 (ES=1.5) GO:0045595,regulation of cell differentiation 11 0.0108
GO:0051094,positive regulation of developmental process 7 0.0349
Cluster 6 (ES=1.4) GO:0048513,organ development 27 0.0037
GO:0007517,muscle organ development 7 0.0104
GO:0007507,heart development 7 0.0114
Cluster 7 (ES=1.3) GO:0001944,vasculature development 7 0.0227
GO:0001568,blood vessel development 7 0.0245
GO biological processes predicted to be stimulated by miRNA downregulation
Cluster 1 (ES=1.3) GO:0022409,positive regulation of cell-cell adhesion 3 0.0003
GO:0022407,regulation of cell-cell adhesion 3 0.0011
Cluster 2 (ES=1.2) GO:0043412,biopolymer modification 9 0.0180
1,2,3are the same as in Table 3.
doi:10.1371/journal.pone.0020509.t004
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targets. We queried ExprTargetDB with the 272 miRNAs
displaying differential expression in senescent IMR90 fibroblasts
(listed in Table S4) by selecting TargetScan as prediction
algorithm and specifying a p-value cutoff of 0.05. Since we
expect an inverse relationship between mRNA and miRNA
expression, we predicted the transcripts targeted by upregulated
miRNAs separately from the ones targeted by downregulated
miRNAs. This analysis yielded two lists of upregulated and
downregulated mRNA transcripts that are potentially regulated
by senescence-induced changes in miRNA expression.
Step2.Geneexpressionprofiling ofsenescence. MIAME-
compliant raw data of mRNA microarrays (Affymetrix Human
Genome U133 Plus 2.0; containing 39,000 genes) were obtained
from the Gene Expression Omnibus repository (accession
number GSE19018). The CEL files GSM470491, GSM470492,
and GSM470493 were from young and GSM470494,
GSM470495, and GSM470496 from senescent IMR90 human
fibroblasts. We used Robust Multichip Average (RMA)
algorithms of the Bioconductor R package affy [60,61] to pre-
process the raw CEL files and normalize the probe expression
levels. Normalized data were tested for differential expression
with the SAM module in the Bioconductor siggenes package
(http://bioconductor.org; [62]) using a cut-off of 15% FDR. A
second set of MIAME-compliant raw data of mRNA two-color
microarrays (NCI/ATC Hs-OperonV2; featuring 21,329 probes)
was obtained from the Gene Expression Omnibus repository
(accession number GSE15919; [63]. This set contains 6 arrays,
which were hybridized with RNAs from MRC5 fibroblasts at
population doubling 63 (senescent) and from MRC5 fibroblasts at
population doubling 28 (young). The six arrays correspond to 3
biological replicates, each with a dye-swap technical replicate.
The arrays were analyzed with Bioconductor limma package
[64,65] to identify genes differentially expressed in senescent
MRC5 fibroblasts. Limma uses linear models to analyze
microarray experiments. Briefly, the intensity data were
imported with a filter so that any spot with a flag of 250 or
less gets zero weight. The flag function assigns a zero to a normal
spot and increasingly negative values for increasingly problematic
spots. We implemented the ‘normexp’ method with an offset of
50 to correct the background and a loess normalization method
(‘printtiploess’) to normalize within arrays. Differentially
expressed genes were obtained by fitting a linear model to the
normalized data followed by computing empirical Bayes statistics.
The dye-effect was included in the model to adjust for any probe-
specific dye effects. The p-values were adjusted for multiple
testing using Benjamini and Hochberg’s method to control the
false discovery rate (FDR). Genes with FDR below 0.05 were
selected as differentially expressed. The differentially expressed
genes were separated into 2 lists of upregulated and
downregulated genes, which we used in the next step of the
analysis.
Step 3. Identification of potential target mRNAs by
matching the in silico predicted miRNA target genes to
experimentally determined microarray mRNA
expression. We identified potential gene targets of the
upregulated miRNAs by comparison of their predicted target
mRNAs (from step 1) with downregulated mRNAs derived from
the senescent IMR90 or MRC5 microarray studies (from step 2).
Similarly, predicted target mRNAs for downregulated miRNAs
were compared to upregulated mRNAs derived from the
microarray study. These genes resulting from matching analysis
of computational prediction of miRNA target genes and
differentially expressed genes in microarray senescence
experiments were considered as genes potentially regulated by
senescence-induced miRNA changes, and were chosen for
downstream functional and pathway analyses.
Functional annotation of miRNA targets
To characterize biological processes affected by senescence-
induced miRNA expression changes, we used Gene Ontology
(GO) and the functional annotation clustering feature of DAVID
[66,67] to functionally annotate genes that are potentially
regulated by miRNAs during senescence. We also used the
clustering analysis to analyze the significance of KEGG pathways
in our data. The functional annotation clustering tool measures
the similarities among GO terms based on the extent of their
associated genes and assembles the similar and redundant GO
terms into annotation clusters. Each GO term in a cluster is
assigned a Fisher Exact p-value representing the degree of
enrichment of the GO term in the input gene list. Each cluster
is assigned an enrichment score to rank its biological significance.
This enrichment score is derived from the geometric mean (in -log
scale) of member’s p-values. Thus, a biologically significant cluster
(high enrichment score) is generated only when most of its GO
term members have significant enrichment values (low Fisher
Exact p-values). The resulting clusters were further curated to keep
only GO terms with p-values ,0.05.
Identification of miRNAs associated with biological
processes altered by senescence
To identify miRNAs that are key regulators of the biological
processes included in the annotation clusters, the GO terms within
each annotation cluster were subjected to computational analysis.
Genes associated with all GO terms within each annotation cluster
were retrieved using DAVID’s genes link (G) provided for each
cluster. This function pools all genes from different GO terms
within a selected cluster into one list. Genes pooled from each
annotation cluster were submitted to the public database of human
miRNA targets (ExprTargetDB) to perform target-centric queries
using the ExprTarget integrative prediction algorithm. MiRNAs
resulting from this analysis were further filtered to keep only
miRNAs with significant prediction scores. These miRNAs are
predicted to be key regulators of the biological processes that are
altered during senescence.
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